Skip to main content
NCBI home page
International Journal of Molecular Sciences logoLink to International Journal of Molecular Sciences
. 2026 Jan 9;27(2):665. doi: 10.3390/ijms27020665

Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777

Hinano Nishikubo 1, Dongheng Ma 1, Tomoya Sano 1, Daiki Imanishi 1, Takashi Sakuma 1, Canfeng Fan 1, Yurie Yamamoto 1, Motohiro Yamamori 2, Masakazu Yashiro 1,3,*
PMCID: PMC12841113  PMID: 41596773

In the original publication [1], the Institutional Review Board Statement and Informed Consent Statement were not included. In addition, the authors modified the Abstract after identifying an error; the phrase “Among 515 FGFR2 alteration cases” to “Among 1312 FGFR2 alteration cases”. The correct Institutional Review Board Statement and Informed Consent Statement appear below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

  • Institutional Review Board Statement: This study was approved by the C-CAT review committee (C-CAT management number: CDU2022-044N on 29 November 2022) and by the medical ethics committee of Osaka Metropolitan University (approval number 2022-111 on 15 September 2022).

  • Informed Consent Statement: Informed consent was waived by the Medical Ethics Committee of Osaka Metropolitan University.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Nishikubo H., Ma D., Sano T., Imanishi D., Sakuma T., Fan C., Yamamoto Y., Yamamori M., Yashiro M. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025;26:10777. doi: 10.3390/ijms262110777. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES